KALA BIO, INC. Conversion of Stock, Shares Issued
KALA BIO, INC. (KALA) had Conversion of Stock, Shares Issued of 16.10 million shares as of 2017-07-25, per its 10-K filed 2019-03-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2019-03-12
- 2017-07-25: Conversion of Stock, Shares Issued 16.10M shares.
| Period end | Conversion of Stock, Shares Issued |
|---|---|
| 2017-07-25 | 16.10M shares 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |